APP and Alzheimer disease: Although the physiological relevance of the fragments generated is not fully understood, one of these, the amyloid-beta peptide (Aβ) originating from the transmembrane domain of the APP protein, is the main component of brain amyloid plaques in Alzheimer’s disease (AD)3,4.